Relation between pro- and anti-inflammatory cytokines and the production of nitric oxide (NO) in severe sepsis

Cytokine

Volumn 9, Issue 2, 1997, Pages 138-142

  Groeneveld, Paul H P ^a   Kwappenberg, Kitty M C ^a   Langermans, Jan A M ^a   Nibbering, Peter H ^a   Curtis, Lloyd ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b British Biotechnology   (United Kingdom)

Author keywords

Cytokines; Nitrate; Nitric oxide; Sepsis

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LEXIPAFANT; NITRIC OXIDE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ARTICLE; BACTEREMIA; BLOOD CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; HUMAN; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLITE; MULTICENTER STUDY; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; STATISTICAL ANALYSIS; VARIANCE;

EID: 0031081462     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0147     Document Type: Article

References (35)

1. 1. Parrillo JE (1993) Pathogenetic mechanisms of septic shock. N Eng J Med 328:1471-1477.
2. 2. Natanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner RL (1994) Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 120:771-783.
3. 3. Girardin E, Grau GE, Dayer JM, Roux-Lombard P, the J5 study group, Lambert PH (1988) Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Eng J Med 319:397-400.
4. 4. Calandra T, Baumgartner JD, Grau GE, Wu MM, Lambert PH, Schellekens J, Verhoef J, Glauser MP, and the Swiss-Dutch J5 Immunoglobulin study group (1990) Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-α, and interferon-γ in the serum of patients with septic shock. J Infect Dis 161:982-987.
5. 5. Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP, and the Swiss-Dutch J5 Immunoglobulin study group (1991) High circulating levels of interleukin-6 in patients with septic shock:evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med 91:23-29.
6. 6. Waage A, Halstensen A, Espevik T (1987) Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet i:355-357.
7. 7. Casey LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119:771-778.
8. 8. Hack CE, Hart M, Strack van Schijndel RJM, Eerenberg AJM, Nuijens JH, Thijs LG, Aarden LA (1992) Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 60:2835-2842.
9. 9. van Deuren M, van der Ven-Jongekrijg J, Demacker PNM, Bartelink AKM, van Dalen R, Sauerwein RW, Gallati H, Vannice JL, van der Meer JWM (1994) Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis 169:157-161.
10. 10. Keuter M, Dharmana E, Hussein Gasem M, van der Ven-Jongekrijg J, Djokomoeljanto R, Dolmans WMV, Demacker P, Sauerwein R, Gallati H, van der Meer JWM (1994) Patterns of proinflammatory cytokines and inhibitors during typhoid fever. J Infect Dis 169:1306-1311.
11. 11. Girardin E, Roux-Lombard P, Grau GE, Suter P, Gallati H, The J5 study group, Dayer JM (1992) Imbalance between tumor necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. Immunology 76:20-23.
12. 12. van der Poll T, Jansen J, van Leenen D, von der Mohlen M, Levi M, ten Cate H, Gallati H, ten Cate JW, van Deventer SJH (1993) Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia. J Infect Dis 168:955-960.
13. 13. Gomez-Jimenez J, Martin MC, Sauri R, Segura RM, Esteban F, Ruiz JC, Nuvials X, Boveda JL, Peracaula R, Salgado A (1995) Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock. J Infect Dis 171:472-475.
14. 14. Marchant A, Deviere J, Bijl B, de Groote D, Vincent JL, Goldman M (1994) Interleukin-10 production during septicaemia. Lancet 343:707-708.
15. 15. Bogdan C, Vodovotz Y, Nathan C (1991) Macrophage deactivation by interleukin-10. J Exp Med 174:1549-1555.
16. 16. Howard M, Muchamuel T, Andrade S, Menon S (1993) Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 177:1205-1208.
17. 17. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822.
18. 18. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012.
19. 19. Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, Simmons RL, Peitzman AB (1991) Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 214:621-626.
20. 20. Evans T, Carpenter A, Kinderman H, Cohen J (1993) Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 41:77-81.
21. 21. Gomez-Jimenez J, Salgado A, Mourelle M, Martin MC, Segura RM, Peracaula R, Moncada S (1995) L-arginine: nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 23:253-258.
22. 22. Wong HR, Carcillo JA, Burckart G, Shah N, Janosky JE (1995) Increased serum nitrite and nitrate concentrations in children with the sepsis syndrome. Crit Care Med 23:835-842.
23. 23. Morris SM, Billiar TR (1994) New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 226:E829-E839.
24. 24. Nussler AK, Di Silvio M, Billiar TR, Hoffman RA, Geller DA, Selby R, Madariaga J, Simmons RL (1992) Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med 176:261-264.
25. 25. Groeneveld PHP, Ringers J, van Dissel JT (1994) Effect of nitric oxide on renal function in septic shock. N Engl J Med 330:1620.
26. 26. Groeneveld PHP, Colson P, Kwappenberg KMC, Clement J (1995) Increased production of nitric oxide (NO) in patients infected with the European variant of Hantavirus. Scand J Infect Dis 27:453-456.
27. 27. van Dissel JT, Groeneveld PHP, Maes B, van Furth R, Frolich M, Feuth HD (1994) Nitric oxide: a predictor of morbidity in postoperative patients? Lancet 343:1579-1580.
28. 28. Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM (1991) Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88:1747-1754.
29. 29. Döcke WD, Syrbe U, Meinecke A, Platzer C, Makki A, Asadullah K, Klug C, Zuckermann H, Reinke P, Brunner H, von Baehr R, Volk HD (1994) Improvement of monocyte function. A new therapeutic approach? In Reinhart K, Eyrich K, Sprung C (eds) Sepsis. Current perspectives in pathophysiology and therapy, Springer-Verlag, Berlin, Heidelberg, New York, p 473-500.
30. 30. Nathan C, Xie Q (1994) Nitric oxide synthases: roles, toles and controls. Cell 78:915-918.
31. 31. Cunha FQ, Moncada S, Liew FY (1992) Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages. Biochem Biophys Res Commun 182: 1155-1159.
32. 32. Wang P, Wu PW, Siegel MI, Egan RW, Billah MM (1994) IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 153:811-816.
33. 33. Lorente JA, Landin L, de Pablo R, Renes E, Liste D (1993) L-arginine pathway in the sepsis syndrome. Crit Care Med 21:1287-1295.
34. 34. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RMH, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644-1655.
35. 35. van Furth AM, Seijmonsbergen EM, Langermans JAM, Groeneveld PHP, de Bel CE, van Furth R (1995) High levels of interleukin-10 and tumor necrosis factor-α in cerebrospinal fluid during the onset of bacterial meningitis. Clin Infect Dis 21:220-222.